HLB Therapeutics Co.,Ltd. (KOSDAQ:115450)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,105.00
-15.00 (-0.71%)
Sep 1, 2026, 3:30 PM KST

HLB Therapeutics Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
11,19820,31117,93423,70945,82199,873
Short-Term Investments
2,0372,5009,5678,64418,101560
Trading Asset Securities
-23,18710,272-89.45134.25
Cash & Short-Term Investments
13,23545,99837,77332,35364,012100,567
Cash Growth
-29.10%21.78%16.75%-49.46%-36.35%249.37%
Accounts Receivable
10,94714,3068,6269,4977,9006,448
Other Receivables
184.83363.75165.82339.49625.471,442
Receivables
11,13214,6708,7929,8378,5278,874
Inventory
6,6117,2375,3735,3366,4552,345
Prepaid Expenses
537.51288.01274.38161.96151.72133.07
Other Current Assets
1,7346,3081,9132,138865.591,333
Total Current Assets
33,24974,50054,12549,82580,012113,253
Property, Plant & Equipment
8,7818,8579,53010,06815,7809,781
Long-Term Investments
63,10643,08961,80458,60820,3353,715
Goodwill
-5,3885,3885,3881,075382.08
Other Intangible Assets
106,2206,5325,3994,8964,2603,925
Long-Term Deferred Tax Assets
2,0072,007----
Long-Term Deferred Charges
-85,59278,28369,10063,47257,586
Other Long-Term Assets
7,3492,6905,2642,9102,7091,070
Total Assets
220,713228,655219,793200,795187,643189,711

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
5,5635,3614,8178,1832,5171,272
Accrued Expenses
1,5271,9251,106902.21,5101,819
Short-Term Debt
36,29010,76817,5317,43651,55150,441
Current Portion of Long-Term Debt
----98-
Current Portion of Leases
1,7721,445450.97624.24297.68364.54
Current Income Taxes Payable
-806.4----
Other Current Liabilities
3,8345,9098,0009,6452,6552,820
Total Current Liabilities
48,98526,21431,90426,79158,62856,717
Long-Term Debt
-25,3595,1701,84048-
Long-Term Leases
2,3742,978200.58122.2136.74320.7
Pension & Post-Retirement Benefits
--454.67328.13520.442,440
Other Long-Term Liabilities
281.08240.42194.81194.81194.81194.81
Total Liabilities
51,64154,79237,92529,27659,52859,672

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
44,29042,19140,07037,01615,99215,668
Additional Paid-In Capital
86,26787,865136,440125,17697,290190,850
Retained Earnings
-2,58810,597-30,176-4,862-1,916-90,644
Treasury Stock
-1,526-1,474-1,120-483.65-413.53-413.53
Comprehensive Income & Other
17,56511,07512,2503,6205,7543,219
Total Common Equity
144,008150,254157,465160,466116,708118,679
Minority Interest
25,06423,61024,40411,05311,40811,360
Shareholders' Equity
169,073173,863181,868171,519128,116130,039
Total Liabilities & Equity
220,713228,655219,793200,795187,643189,711

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
40,43640,55023,35310,02252,13151,126
Net Cash (Debt)
-27,2015,44814,42022,33011,88149,441
Net Cash Growth
--62.22%-35.42%87.95%-75.97%219.98%
Net Cash Per Share
-308.5961.84170.82273.07166.30767.17
Filing Date Shares Outstanding
87.7883.9683.7481.2636.1473.28
Total Common Shares Outstanding
87.7883.9687.9381.2672.2973.28
Working Capital
-15,73748,28622,22123,03421,38456,536
Book Value Per Share
1640.621789.641790.841974.621614.491619.44
Tangible Book Value
37,788138,334146,678150,182111,372114,372
Tangible Book Value Per Share
430.501647.661668.161848.081540.681560.66
Land
-1,4394,4294,4295,9164,429
Buildings
-2,5065,3005,1508,4675,146
Machinery
-7,8297,7112,92710,2532,737
Construction In Progress
-16.25--263.3-